Fresh insights into how a common virus replicates could pave the way for new therapies to stop its spread.
Scientists have discovered a key molecule linked to Human Cytomegalovirus (HCMV) infection, which is harmless for healthy people but can cause miscarriage and birth defects during pregnancy.
Tests on infected cells found that blocking the molecule with a chemical inhibitor stops the virus from multiplying.
The molecule -- called VCP -- is a component of the infected cell rather than a substance produced by the virus itself.
Researchers at the University of Edinburgh's Roslin Institute found the virus is dependent on VCP to replicate its genetic material and multiply.
Chemicals that block the activity of VCP are 10 times more powerful at stopping the virus than existing medications that target HCMV directly, the study found.
By targeting the affected cells instead of the virus, the approach could also cut the chances of the virus becoming resistant to the therapy, researchers say.
Drugs that target VCP are already being developed as potential therapies for cancer. Studies to check whether the drugs are safe for use will be needed before they could be tested as a therapy for the virus.
HCMV is extremely common. It infects at least 30 per cent of the population in the developed world and up to 100 per cent of people in developing countries.
It can be life-threatening for people with a weakened immune system, such as transplant recipients and people infected with HIV.
Infection during pregnancy can lead to hearing loss and intellectual disabilities in unborn babies.
The study is published in the journal PLOS Pathogens.
Dr Finn Grey, a Senior Research Fellow at the University of Edinburgh's Roslin Institute, said: "Human Cytomegalovirus infection is an important human disease. By gaining a better understanding of how the virus works, we can develop improved antiviral drugs. While more work is required, this study shows the potential of such approaches."
Materials provided by University of Edinburgh. Note: Content may be edited for style and length.
Disclaimer: DoveMed is not responsible for the accuracy of the adapted version of news releases posted to DoveMed by contributing universities and institutions.
Primary Resource:
Yao-Tang Lin, James Prendergast, Finn Grey. The host ubiquitin-dependent segregase VCP/p97 is required for the onset of human cytomegalovirus replication. PLOS Pathogens, 2017; 13 (5): e1006329 DOI: 10.1371/journal.ppat.1006329
and connect with fellow professionals
At DoveMed, our utmost priority is your well-being. We are an online medical resource dedicated to providing you with accurate and up-to-date information on a wide range of medical topics. But we're more than just an information hub - we genuinely care about your health journey. That's why we offer a variety of products tailored for both healthcare consumers and professionals, because we believe in empowering everyone involved in the care process.
Our mission is to create a user-friendly healthcare technology portal that helps you make better decisions about your overall health and well-being. We understand that navigating the complexities of healthcare can be overwhelming, so we strive to be a reliable and compassionate companion on your path to wellness.
As an impartial and trusted online resource, we connect healthcare seekers, physicians, and hospitals in a marketplace that promotes a higher quality, easy-to-use healthcare experience. You can trust that our content is unbiased and impartial, as it is trusted by physicians, researchers, and university professors around the globe. Importantly, we are not influenced or owned by any pharmaceutical, medical, or media companies. At DoveMed, we are a group of passionate individuals who deeply care about improving health and wellness for people everywhere. Your well-being is at the heart of everything we do.
0 Comments
Please log in to post a comment.